Skip Navigation

Rheumatology 2008 47(1):92-95; doi:10.1093/rheumatology/kem315
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Healy, P. J.
Right arrow Articles by Helliwell, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Healy, P. J.
Right arrow Articles by Helliwell, P. S.
Related Collections
Right arrow Spondylarthropathies
Right arrow Diagnostics and Imaging Procedures
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

MRI changes in psoriatic dactylitis—extent of pathology, relationship to tenderness and correlation with clinical indices

P. J. Healy1,2, C. Groves2, M. Chandramohan2 and P. S. Helliwell1,2

1Academic Unit of Musculoskeletal Medicine, University of Leeds, Leeds and 2Bradford Teaching Hospitals, NHS Trust, West Yorkshire, UK.

Correspondence to: P. Helliwell, Academic Unit of Musculoskeletal Medicine, University of Leeds, 36 Clarendon Road, Leeds LS2 9NZ, UK. E-mail: p.helliwell{at}leeds.ac.uk


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Acknowledgements
 References
 
Objectives. To quantify the extent of inflammation in psoriatic dactylitis and to examine the relationship between clinical and magnetic resonance imaging (MRI) data in both tender and non-tender dactylitis.

Methods. Seventeen patients with psoriatic dactylitis underwent clinical assessment for 6 months after change of treatment, usually to methotrexate. Measures of dactylitis included the Leeds Dactylitis Index, the assessment tool used in the Infliximab in Psoriatic Arthritis Clinical Trial (IMPACT), a simple count of tender dactlylitic digits and a count of all dactylitic digits, both tender and non-tender. MRI scans of the affected hand or foot were performed before and after treatment using a 1.5T Siemen's scanner pre- and post-contrast.

Results. All patients improved clinically, as did their respective dactylitis scores and MRI images. The findings on MRI in both dactylitic and non-dactylitic digits were profound and widespread. The difference between tender and non-tender dactylitis was quantitative rather than qualitative. Synovitis and soft-tissue oedema were the most frequent abnormalities being present in 69% of tender dactylitic digits but bone oedema and flexor tenosynovitis were also frequently seen. Soft-tissue oedema was circumferential and enhancing and not limited to association with the flexor or extensor tendons. None of the clinical indices of dactylitis showed a close relationship to the extent of MRI abnormalities.

Conclusions. MRI images demonstrate widespread abnormalities in digits of people with psoriatic arthritis. Tender dactylitic digits have more abnormalities than other digits but the relationship between clinical and MRI scores is not strong.

KEY WORDS: Psoriatic arthritis, Dactylitis, Magnetic resonance imaging, Measurement, Outcome assessment, Clinical trials


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Acknowledgements
 References
 
Dactylitis is considered a hallmark feature of psoriatic arthritis (PsA) occurring in 16–24% of reported cases. It is characterized by diffuse swelling of a digit. According to a recent paper from Toronto, the lifetime incidence of dactylitis in PsA is 48% and the prevalence 33% [1]. Tender dactylitis is associated with more aggressive disease in affected digits—the above study found radiological disease progression in 50% of finger and toe joints in those with dactylitis, but in only 38% in those without.

One of the problems with dactylitis is the existence of a chronic non-tender form. It is unknown whether this form is simply resolving tender dactylitis, a low-grade version of tender dactylitis or a different pathological process entirely. A number of recent studies have addressed the pathophysiology of dactylitis using recently developed imaging techniques.

Olivieri et al. [2], using magnetic resonance imaging (MRI) and ultrasound (US), described flexor tenosynovitis mostly with occasional synovitis and soft-tissue oedema in the hands. There were similar findings in a study of 12 toes, though subcutaneous oedema was noted in two cases [3]. Further publications showed flexor tendon sheath involvement [4–6]. No evidence of a major role for enthesitis in dactylitis was found in these studies [7] but synovitis and mild oedema of the peritendinous tissues was seen.

A US study by Kane et al. [8] found flexor tenosynovitis in 24 of 25 dactylitic digits and joint synovitis in 52%. Subcutaneous oedema was noted in all affected digits, but authors were unable to further quantify it. A further power-Doppler US study by Fournie and colleagues [9], looking at fingers not selected for dactylitis, found soft-tissue thickening (termed ‘pseudotenosynovitis’) in 8 of 25 digits studied.

McGonagle et al. [10] rekindled interest in enthesitis as the underlying cause of the clinical manifestations of PsA hypothesizing that in dactylitis it is primarily enthesitis, either at tendon insertion, or at functional entheses, which causes inflammation in adjacent tissues by diffusion of cytokines. In this respect, a recent US study from France found frequent enthesopathy at the insertion of the flexor tendon into the terminal digit, capsular hyperostosis and periarticular periostitis [11].

The current study links clinical and MRI data in cases of both tender and non-tender dactylitis both before and after treatment and introduces a new MRI scoring system for quantifying the extent of inflammatory change in dactylitic digits.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Acknowledgements
 References
 
The study took place in a secondary care setting in Bradford NHS Trust in West Yorkshire, United Kingdom. Approval was given by the local ethics committee. Patients with active disease, i.e. who were intolerant or unresponsive to their current disease-modifying therapies or had not yet begun disease-modifying therapy and presented with dactylitis were invited to participate as they presented to the out-patient rheumatology clinic. A full study information sheet and written consent form was provided. Those who provided written consent to participate underwent an initial assessment of joint and skin disease. Drug therapy was chosen by the managing clinician as was considered appropriate. Patients underwent further clinical assessments at baseline (start of new drug therapy), 2 weeks, 1 month, 3 months and 6 months. MRI scanning was performed as soon as possible after the baseline assessment and after the 6-month visit. Further methodology and full details of the clinical responses are given elsewhere [12].

Clinical assessment included the following instruments to assess dactylitis:

  • Leeds Dactylitis Instrument (LDI) and LDI basic. The LDI measures the ratio of the circumference of the affected digit to the circumference of the digit on the opposite hand or foot: using a minimum difference of 10% to define a dactylitic digit. The ratio of circumference is multiplied by a tenderness score, originally based on the Ritchie index (graded 0–3) but a later modification amended this to a binary score (0 for non-tender, 1 for tender—this later modification is referred to as the LDI-basic) [13].
  • Clegg. This score simply counts the number of digits thought to have dactylitis, both tender and non-tender [14].
  • Tender that counts the number of digits with tender dactylitis [15].
  • IMPACT used a 0–3 scale of physician-rated severity for each affected digit and added the results with a maximum score of 60 [16].

MRI protocol and scoring procedure
The MR scans were performed with a Siemens Avanto 1.5T magnet using a shoulder coil. Coronal T1-weighted TSE (Turbo spin echo) and STIR (short Tau inversion recovery) sequences of the whole hand/foot were obtained followed by T1-weighted, STIR and post-gadolinium fat-suppressed T1-weighted sequences of the affected and adjacent digits in both sagittal and axial planes.

The following eight features were scored blind by two observers (C.G., M.C., both experienced musculoskeletal radiologists) working in tandem, with the final scores achieved by consensus. Inter- and intra-observer reliability was not formally assessed. Each feature was noted as present/absent at each of three levels of the digit: metacarpophalangeal joint, proximal inter-phalangeal joint and distal inter-phalangeal joint.

  • Synovitis (capsular enhancement and intracapsular fluid).
  • Bone oedema.
  • Subcutaneous oedema.
  • Flexor tenosynovitis (peritendinous fluid and enhancement).
  • Extensor tenosynovitis (peritendinous fluid and enhancement).
  • Plantar/volar plate enhancement.
  • Collateral ligament enhancement.
  • Erosions.

In addition, the presence of sesamoiditis at the thumb and great toe was assessed. An MRI score was developed for each digit with one point allocated for the presence of each feature at each joint level and a total score obtained by the simple summation of these features (maximum score for each of the second through fifth digits, 24; for the first digit, 17).

Statistical analysis
The data were analysed using SPSS 12.0. Descriptive statistics are mean values with standard deviations. Means are compared using independent t-tests. Correlations are made using the non-parametric Spearman {rho} statistic. Proportions were compared using a pooled variance method and the standardized normal deviate [17]. Generally, P-values of less than 0.05 were considered significant.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Acknowledgements
 References
 
Seventeen patients were scanned pre-treatment: 10 males and 7 females, 4 hands with dactylitis, 13 feet. The mean age was 44 (S.D. 12.4) yrs and mean duration of disease 6.3 (S.D. 8.6) yrs. The mean tender joint count was 11.6 (S.D. 6.3) and the swollen joint count was 9.5 (S.D. 3.4). Methotrexate was initiated in 12 patients, etanercept in 1, infliximab in 1 and hydroxychloroquine in 1. In two patients, the treatment remained unchanged.

Nine patients declined a follow-up scan. Eight patients were scanned at an average of 7 weeks following the end of the study period. Patients having a treatment change showed a good response to treatment with acceptable PsARC and ACR20 responses at both 3 and 6 months.

All the clinical indices of dactylitis improved during the 6-month observation, as did the MRI scores for the hand or foot in question (average first MRI score 20.6, S.D. 9.2; average second MRI 9.0, S.D. 6.7). However, the relationship between clinical and MRI scores was not strong: correlations between clinical scores for individual dactylitic digits and their respective aggregate MRI scores (for that digit only) were 0.37 for LDI local score (significant at 5% level) and 0.21 for local IMPACT (not significant). The coefficients for the relationship between total aggregate clinical dactylitis scores and total MRI scores for the respective hand or foot are given in Table 1. None of the clinical scores demonstrated a significant relationship with the MRI scores but the clinical scores show good inter-score relationships. The poor correlation was not unidirectional—clinical scores were low in the presence of high MRI scores but the converse was also true.


View this table:
[in this window]
[in a new window]

 
TABLE 1. Relationship between clinical and MRI variables

 
MRI findings
Table 2 gives the aggregate MRI scores for tender and non-tender dactylitic digits together with the aggregate scores for the other non-dactylitic, comparator digits imaged at the same time in the same hand or foot. It will be appreciated that the MRI score for tender dactylitis exceeds that for non-tender dactylitis and scores for the other digits. However, prominent abnormalities in the other digits of the same hand or foot were frequently seen, as reflected in these scores. Further, abnormalities on MRI persisted in non-tender dactylitis despite clinical improvement following treatment. However, scores for non-tender dactylitis hardly exceed scores in other, non-dactylitic digits.


View this table:
[in this window]
[in a new window]

 
TABLE 2. MRI scores for tender and non-tender dactylitic digits compared with non-dactylitic digits

 
The images revealed a polyarticular disease process with a number of contributing pathologies and a spectrum of severity. The proximal joints were involved with a greater degree of severity than the distal joints. Synovitis and soft-tissue oedema were the most frequent abnormalities being present in 69% of tender dactylitic digits and 63 and 58%, respectively, of non-tender dactylitic digits. The soft-tissue oedema was circumferential and enhancing and not limited to association with the flexor or extensor tendons. A spectrum of bone oedema was observed ranging from periarticular adjacent to the capsular insertions, to oedema involving the whole of the phalanx. Subtle bone oedema became more apparent after contrast administration. Flexor tenosynovitis was a common finding, with extensor tenosynovitis observed less frequently. Erosions were uncommon. Examples of the abnormalities are shown in Figs 1 and 2.


Figure 1
View larger version (99K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
FIG. 1. (a) Sagittal MR index finger (gadolinium-enhanced T1W fat saturation) showing distension of the proximal inter-phalangeal joint (PIPJ) capsule due to synovitis (arrow). The flexor tendon is displaced away from the proximal and middle phalanges by tenosynovitis. (b) Axial forefoot MR (gadolinium-enhanced T1W fat saturation) showing circumferential soft tissue oedema involving the fourth toe and extending proximally to the fourth metatarsophalangeal joint (MTPJ) plantar surface. The flexor tendon is displaced away from the phalanx by tenosynovitis (arrow). There is also early involvement of the second and third toes. (c) Axial forefoot MR (short tau inversion recovery) at the level of the distal metatarsals showing synovitis encasing the great toe flexor tendon (arrow).

 

Figure 2
View larger version (95K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
FIG. 2. (a) Coronal forefoot MR (gadolinium-enhanced T1W fat saturation) showing bone oedema involving the second toe proximal phalanx. Bone oedema is also present at the collateral origins in the second metatarsal head (double headed arrow). The second MTPJ collateral has enhanced (arrow) in keeping with enthesitis. (b) Coronal forefoot MR (gadolinium-enhanced T1W fat saturation), similar appearances to Fig. 2a but demonstrating involvement of the first, third and fourth digits in addition to the dactylitic second digit.

 
As the digits were scored by region, a breakdown of the scores is given by individual features in Table 3. Synovitis, bone oedema, soft tissue oedema and flexor tenosynovitis contributed most to the total MRI score. The main, statistically significant contrast between tender and non-tender dactylitis was the relatively infrequent presence of bone oedema in the non-tender cohort (difference in proportions 0.25, P = 0.02). Extensor tenosynovitis, plantar/volar plate enhancement, collateral enhancement and erosions were not seen in the non-tender group.


View this table:
[in this window]
[in a new window]

 
TABLE 3. The frequency of individual MRI features for tender and non-tender dactylitic digits

 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Acknowledgements
 References
 
Dactylitis is considered an important feature of PsA, occurring in 16–24% of the reported cases. Dactylitis is an adverse prognostic sign and is associated with more erosive disease in affected digits [1]. The importance of dactylitis in PsA is further supported by its inclusion in the recently developed classification criteria for PsA [18]. The current study has revealed the extent of pathological change underlying both tender and non-tender dactylitis and, for the first time, the extent of soft-tissue oedema in affected digits. The study has also demonstrated a poor relationship between clinical and MRI assessment of dactylitis.

Other imaging studies have shown both tenosynovitis and synovitis as the major underlying pathology of dactylitis in PsA [2, 8]. The US studies by Kane et al. [8] and also Fournie et al. [9] demonstrated soft tissue oedema but the authors were unable to assess the extent due to the limitations of their technology. This is the first study to show circumferential soft tissue oedema in the majority of cases studied. It is also the first to recognize a spectrum of bone oedema within the affected digits. No doubt this difference is due to technological advances and difference in techniques between the earlier studies and the current one.

What does this study tell us about the underlying pathophysiology of dactylitis in PsA? The profound and extensive inflammation in tender dactylitis is unsurprising given the clinical findings but it is more surprising that the cases of non-tender dactylitis also demonstrated such widespread abnormalities. It is worth noting, however, that one of the main differences between tender and non-tender dactylitis was the more frequent bone oedema in the former. The concept of a ‘snapshot in time’ could explain the apparent spectrum in the severity of bone oedema observed between cases. We hypothesize that bone oedema begins at the corner of a phalanx at the insertion of the capsule (Fig. 2a), and then spreads to involve the whole bone as the disease progresses. Plantar/volar plate and collateral enhancement was also seen exclusively in the tender dactylitis cohort. It is therefore possible that an enthesitic process, as postulated by McGonagle et al. [10] is involved in the tender dactylitis group. However, the paradox of PsA remains—why should the digits develop such widespread inflammation across the different tissues? McGonagle et al. [10] hypothesize that the primary lesion is at the enthesis and that all other inflammatory change in the digit follows by diffusion of cytokines from this site but there is no confirmatory evidence for this hypothesis. Why, for example, doesn't the same process occur in the severe synovitis of rheumatoid arthritis? Finally, the relative paucity of erosions seen in this study probably reflects the fact that many of these patients had short duration disease, with two-thirds having a disease duration of ≤6 yrs.

MRI score
The MRI score, proposed here, may be of use as an outcome measure in clinical trials that incorporate imaging. Clearly, cost and patient acceptability are two important considerations but the score has been shown to be responsive and is linked to the underlying pathophysiology. Unfortunately, correlations between the MRI score and the clinical scores were poor, but this is not surprising as similar findings have been reported for the assessment of synovitis, where MRI demonstrates more widespread abnormalities than are appreciated clinically [19]. Further development is necessary, including data on reliability. Of interest is a recent paper from OMERACT 8 which has shown moderate reliability for an MRI score incorporating the features of erosion, bone oedema, synovitis, tendinopathy and extra-capsular features [20]. The study was, however, based on a small number of images and clinical data was not given so it is not known if digits with dactylitis were included.

The OMERACT filter is intended to help evaluate the overall usefulness of an outcome measure providing a good framework with which to assess an instrument. Of the available clinical measures for assessing dactylitis in PsA only the LDI has undergone rigorous evaluation. The measure provides an intrinsic definition of dactylitis clinically (10% difference in circumference between the affected digit and its opposite digit on the other hand or foot) and a measure of the degree of inflammation within the digit (assessed on a 3-point scale of tenderness to palpation). Our understanding of the pathophysiology suggests that a measure encompassing oedema or swelling might be a more accurate, or true, indicator of disease. In this study, only the ipsilateral LDI score was significantly correlated with the MRI aggregate score for that digit, albeit that the association was not very strong. In terms of the truth domain of the OMERACT filter, therefore, the LDI would appear to have an advantage over the alternative measures.


    Conclusions
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Acknowledgements
 References
 
MRI has revealed a polyarticular disease process with a spectrum of abnormalities in psoriatic dactylitis. These abnormalities were weakly correlated with local clinical scores although overall clinical and MRI associations were not significant. Both clinical and MRI scores respond appropriately to treatment with conventional non-biologic disease-modifying drugs.

Formula


    Acknowledgements
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Acknowledgements
 References
 
Funding: We thank the following for financial support: P.J.H. was supported by a scholarship from the Rose Hellaby Trust, New Zealand. Financial support for the study was provided by the Group for Study of Psoriasis and Psoriatic Arthritis (GRAPPA) and by an unrestricted grant from Sanofi-Aventis.

Disclosure statement: The authors have declared no conflicts of interest.


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Acknowledgements
 References
 

  1. Brockbank JE, Stein M, Schentag CT, Gladman D. Dactylitis in psoriatic arthritis: a marker for disease severity. Ann Rheum Dis (2005) 64:188–90.[Abstract/Free Full Text]
  2. Olivieri I, Barozzi L, Favaro L, et al. Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum (1996) 39:1524–8.[Web of Science][Medline]
  3. Olivieri I, Barozzi L, Pierro A, De Matteis M, Padula A, Pavlica P. Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging. J Rheumatol (1997) 24:926–30.[Web of Science][Medline]
  4. Padula A, Salvarani C, Barozzi L, et al. Dactylitis also involving the synovial sheaths in the palm of the hand: two more cases studied by magnetic resonance imaging. [comment]. Ann Rheum Dis (1998) 57:61–2.[Web of Science][Medline]
  5. Olivieri I, Scarano E, Padula A, Giasi V. Dactylitis of the thumb extending into the radial bursa. J Rheumatol (2003) 30:1626–7.[Free Full Text]
  6. Olivieri I, Scarano E, Padula A, Giasi V. Dactylitis involving most of the fingers. Clin Experiment Rheumatol (2003) 21:406.[Web of Science][Medline]
  7. Olivieri I, Salvarani C, Cantini F, et al. Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum (2002) 46:2964–7.[CrossRef][Web of Science][Medline]
  8. Kane D, Greaney T, Bresnihan B, Gibney R, FitzGerald O. Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol (1999) 26:1746–51.[Web of Science][Medline]
  9. Fournie B, Margarit–Coll N, Champetier de Ribes TL, et al. Extrasynovial ultrasound abnormalities in the psoriatic finger. Prospective comparative power-doppler study versus rheumatoid arthritis. Joint, Bone, Spine: Rev Rhumatis (2006) 73:527–31.[CrossRef]
  10. McGonagle D, Conaghan P, Emery P. Psoriatic arthritis: a unified concept 20 years on. Arthritis Rheum (1999) 42:1080–6.[CrossRef][Web of Science][Medline]
  11. Champetier de Ribes TL, Margarit-Coll N, Sans N, et al. [Ultrasound features of entesopathy in patients with psoriatic dactylitis]. [French]. J Radiologie (2006) 87(6 Pt 1):639–45.
  12. Healy PJ, Helliwell PS. Measuring dactylitis in clinical trials: which is the best instrument to use? J Rheumatol (2007) 34:1302–6.[Abstract/Free Full Text]
  13. Helliwell PS, Firth J, Ibrahim GH, Melsom RD, Shah I, Turner DE. Development of an assessment tool for dactylitis in psoriatic arthritis. J Rheumatol (2005) 32:1745–50.[Abstract/Free Full Text]
  14. Clegg DO, Reda DJ, Mejias E, et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 39:2013–20.[Web of Science][Medline]
  15. Salvarani C, Macchioni P, Olivieri I, et al. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol (2001) 28:2274–82.[Abstract/Free Full Text]
  16. Antoni C, Dechant C, Hanns-Martin Lorenz PD, et al. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum (2002) 47:506–12.[CrossRef][Web of Science][Medline]
  17. Armitage P, Berry G. Statistical methods in medical research (1987) 2nd. Oxford: Blackwell Scientific.
  18. Taylor WJ, Gladman DD, Helliwell PS, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum (2006) 54:2665–73.[CrossRef][Web of Science][Medline]
  19. Ostergaard M, Stoltenberg M, Henriksen O, Lorenzen I. Quantitative assessment of synovial inflammation by dynamic gadolinium-enhanced magnetic resonance imaging. A study of the effect of intra-articular methylprednisolone on the rate of early synovial enhancement. Br J Rheumatol (1996) 35:50–9.[Abstract/Free Full Text]
  20. McQueen F, Lassere M, Bird P, et al. Developing a magnetic resonance imaging scoring system for peripheral psoriatic arthritis. J Rheumatol (2007) 34:859–61.[Abstract/Free Full Text]
Submitted 7 August 2007; revised version accepted 29 October 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
P. A. NIGROVIC
Juvenile Psoriatic Arthritis: Bathwater or Baby?
J Rheumatol, September 1, 2009; 36(9): 1861 - 1863.
[Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
F. McQUEEN, M. LASSERE, A. DUER-JENSEN, C. WIELL, P. G. CONAGHAN, F. GANDJBAKHCH, K.-G. A. HERMANN, P. BIRD, P. BOYESEN, C. PETERFY, et al.
Testing an OMERACT MRI Scoring System for Peripheral Psoriatic Arthritis in Cross-sectional and Longitudinal Settings
J Rheumatol, August 1, 2009; 36(8): 1811 - 1815.
[Abstract] [Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
M. OSTERGAARD, F. McQUEEN, C. WIELL, P. BIRD, P. BOYESEN, B. EJBJERG, C. PETERFY, F. GANDJBAKHCH, A. DUER-JENSEN, L. COATES, et al.
The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System (PsAMRIS): Definitions of Key Pathologies, Suggested MRI Sequences, and Preliminary Scoring System for PsA Hands
J Rheumatol, August 1, 2009; 36(8): 1816 - 1824.
[Abstract] [Full Text] [PDF]


Home page
The Journal of Rheumatology SupplementHome page
P. S. HELLIWELL
Established Psoriatic Arthritis: Clinical Aspects
J Rheumatol Suppl, August 1, 2009; 83(0): 21 - 23.
[Abstract] [Full Text] [PDF]


Home page
The Journal of Rheumatology SupplementHome page
M. A. CIMMINO, M. PARODI, G. ZAMPOGNA, F. PAPARO, E. SILVESTRI, G. GARLASCHI, and R. SCARPA
Magnetic Resonance Imaging of the Hand in Psoriatic Arthritis
J Rheumatol Suppl, August 1, 2009; 83(0): 39 - 41.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
I. Olivieri, S. D'Angelo, E. Scarano, and A. Padula
What is the primary lesion in SpA dactylitis?
Rheumatology, May 1, 2008; 47(5): 561 - 562.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Healy, P. J.
Right arrow Articles by Helliwell, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Healy, P. J.
Right arrow Articles by Helliwell, P. S.
Related Collections
Right arrow Spondylarthropathies
Right arrow Diagnostics and Imaging Procedures
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?